Page 11234..1020..»

You are currently browsing the Nano Medicine category

COVID-19 Impact on Global and Regional Nanomedicine Industry Production, Sales and Consumption Status and Prospects Professional Market Research…

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on COVID-19 Impact on Global and Regional Nanomedicine Industry Production, Sales and Consumption Status and Prospects Professional Market Research…

The global Nanomedicine market focuses on encompassing major statistical evidence for the Nanomedicine industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Nanomedicine study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked.

This intelligence and 2026 forecasts Nanomedicine industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and sets a precedented growth trajectory for the Nanomedicine market. The report also focuses on a comprehensive market revenue streams along with growth patterns, analytics focused on market trends, and the overall volume of the market.

Moreover, the Nanomedicine report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. The market segmentation clarifies further regional distribution for the Nanomedicine market, business trends, potential revenue sources, and upcoming market opportunities.

Download PDF Sample of Nanomedicine Market report @ https://hongchunresearch.com/request-a-sample/2923

Major Players in Nanomedicine market are:, Fraunhofer ICT-IMM, Tecnalia, Bergmannstrost, CIC biomaGUNE, Bracco, Affilogic, LTFN, GIMAC, Endomagnetics, Materials Research Centre, VITO NV, CIBER-BBN, Istec CNR, Carlina technologies, Cristal Therapeutics, ChemConnection, IMDEA, SwedNanoTech, Grupo Praxis, Vicomtech, DTI, Tekniker, Biotechrabbit, Contipro, , Major Regions that plays a vital role in Nanomedicine market are:, North America, Europe, China, Japan, Middle East & Africa, India, South America, Others

Most important types of Nanomedicine products covered in this report are:, Type 1, Type 2, Type 3, Type 4, Type 5

Brief about Nanomedicine Market Report with [emailprotected] https://hongchunresearch.com/report/Nanomedicine-market-2923

Most widely used downstream fields of Nanomedicine market covered in this report are:, Application 1, Application 2, Application 3, Application 4, Application 5

The Nanomedicine market study further highlights the segmentation of the Nanomedicine industry on a global distribution. The report focuses on regions of North America, Europe, Asia, and the Rest of the World in terms of developing business trends, preferred market channels, investment feasibility, long term investments, and environmental analysis. The Nanomedicine report also calls attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.

In addition, the Nanomedicine market study also covers several factors such as market status, key market trends, growth forecast, and growth opportunities. Furthermore, we analyze the challenges faced by the Nanomedicine market in terms of global and regional basis. The study also encompasses a number of opportunities and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.

The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with primary and secondary research methodologies. It covers all the bases surrounding the Nanomedicine industry as it explores the competitive nature of the market complete with a regional analysis.

Some Point of Table of Content:

Chapter One: Nanomedicine Introduction and Market Overview

Chapter Two: Industry Chain Analysis

Chapter Three: Global Nanomedicine Market, by Type

Chapter Four: Nanomedicine Market, by Application

Chapter Five: Global Nanomedicine Production, Value ($) by Region (2014-2019)

Chapter Six: Global Nanomedicine Production, Consumption, Export, Import by Regions (2014-2019)

Chapter Seven: Global Nanomedicine Market Status and SWOT Analysis by Regions

Chapter Eight: Competitive Landscape

Chapter Nine: Global Nanomedicine Market Analysis and Forecast by Type and Application

Chapter Ten: Nanomedicine Market Analysis and Forecast by Region

Chapter Eleven: New Project Feasibility Analysis

Chapter Twelve: Research Finding and Conclusion

Chapter Thirteen: Appendix continued

List of tables List of Tables and Figures

Figure Product Picture of Nanomedicine

Table Product Specification of Nanomedicine

Figure Market Concentration Ratio and Market Maturity Analysis of Nanomedicine

Figure Global Nanomedicine Value ($) and Growth Rate from 2014-2024

Table Different Types of Nanomedicine

Figure Global Nanomedicine Value ($) Segment by Type from 2014-2019

Figure Nanomedicine Type 1 Picture

Figure Nanomedicine Type 2 Picture

Figure Nanomedicine Type 3 Picture

Figure Nanomedicine Type 4 Picture

Figure Nanomedicine Type 5 Picture

Table Different Applications of Nanomedicine

Figure Global Nanomedicine Value ($) Segment by Applications from 2014-2019

Figure Application 1 Picture

Figure Application 2 Picture

Figure Application 3 Picture

Figure Application 4 Picture

Figure Application 5 Picture

Table Research Regions of Nanomedicine

Figure North America Nanomedicine Production Value ($) and Growth Rate (2014-2019)

Figure Europe Nanomedicine Production Value ($) and Growth Rate (2014-2019)

Table China Nanomedicine Production Value ($) and Growth Rate (2014-2019)

Table Japan Nanomedicine Production Value ($) and Growth Rate (2014-2019) continued

About HongChun Research: HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details: Jennifer Gray Manager Global Sales + 852 8170 0792 [emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

More:
COVID-19 Impact on Global and Regional Nanomedicine Industry Production, Sales and Consumption Status and Prospects Professional Market Research...

Read the Rest...

Jennifer.grey The Daily Chronicle – The Daily Chronicle

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Jennifer.grey The Daily Chronicle – The Daily Chronicle

The global Embedded Telematics Electronic Control Unit (Ecu) market focuses on encompassing major statistical evidence for the Embedded Telematics Electronic Control Unit (Ecu) industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Embedded Telematics Electronic Control Unit (Ecu) study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked.

This intelligence and 2026 forecasts Embedded Telematics Electronic Control Unit (Ecu) industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and sets a precedented growth trajectory for the Embedded Telematics Electronic Control Unit (Ecu) market. The report also focuses on a comprehensive market revenue streams along with growth patterns, analytics focused on market trends, and the overall volume of the market.

Moreover, the Embedded Telematics Electronic Control Unit (Ecu) report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. The market segmentation clarifies further regional distribution for the Embedded Telematics Electronic Control Unit (Ecu) market, business trends, potential revenue sources, and upcoming market opportunities.

Download PDF Sample of Embedded Telematics Electronic Control Unit (Ecu) Market report @ https://hongchunresearch.com/request-a-sample/3752

Major Players in Embedded Telematics Electronic Control Unit (Ecu) market are:, Fujitsu Limited (Japan), Pioneer Corporation (Japan), Honda Motor Co., Ltd (Japan), Denso Corporation (Japan), NXP Semiconductors N.V. (Netherlands), Delphi Automotive LLP (UK), Garmin Ltd. (Switzerland), Texas Instruments Incorporated (USA), Audi AG (Germany), Freescale Semiconductor Inc. (USA), Clarion Corporation of America (USA), Ford Motor Company (USA), Infotainment Semiconductor Manufacturers, Infotainment Systems Manufacturers, Harman International (USA), NavTeq Corporation (USA), Volkswagen AG (Germany), Lexus International (Japan), Continental Automotive GmbH (Germany), Toyota Motor Corp. (Japan), Panasonic Corporation (Japan), Robert Bosch GmbH (Germany), TomTom International BV. (The Netherlands), Flextronics International (Singapore), General Motors Corp. (USA), , Major Regions that plays a vital role in Embedded Telematics Electronic Control Unit (Ecu) market are:, North America, Europe, China, Japan, Middle East & Africa, India, South America, Others

Most important types of Embedded Telematics Electronic Control Unit (Ecu) products covered in this report are:, Type 1, Type 2, Type 3, Type 4, Type 5

Brief about Embedded Telematics Electronic Control Unit (Ecu) Market Report with [emailprotected] https://hongchunresearch.com/report/Embedded Telematics Electronic Control Unit (Ecu)-market-3752

Most widely used downstream fields of Embedded Telematics Electronic Control Unit (Ecu) market covered in this report are:, Application 1, Application 2, Application 3, Application 4, Application 5

The Embedded Telematics Electronic Control Unit (Ecu) market study further highlights the segmentation of the Embedded Telematics Electronic Control Unit (Ecu) industry on a global distribution. The report focuses on regions of North America, Europe, Asia, and the Rest of the World in terms of developing business trends, preferred market channels, investment feasibility, long term investments, and environmental analysis. The Embedded Telematics Electronic Control Unit (Ecu) report also calls attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.

In addition, the Embedded Telematics Electronic Control Unit (Ecu) market study also covers several factors such as market status, key market trends, growth forecast, and growth opportunities. Furthermore, we analyze the challenges faced by the Embedded Telematics Electronic Control Unit (Ecu) market in terms of global and regional basis. The study also encompasses a number of opportunities and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.

The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with primary and secondary research methodologies. It covers all the bases surrounding the Embedded Telematics Electronic Control Unit (Ecu) industry as it explores the competitive nature of the market complete with a regional analysis.

Some Point of Table of Content:

Chapter One: Embedded Telematics Electronic Control Unit (Ecu) Introduction and Market Overview

Chapter Two: Industry Chain Analysis

Chapter Three: Global Embedded Telematics Electronic Control Unit (Ecu) Market, by Type

Chapter Four: Embedded Telematics Electronic Control Unit (Ecu) Market, by Application

Chapter Five: Global Embedded Telematics Electronic Control Unit (Ecu) Production, Value ($) by Region (2014-2019)

Chapter Six: Global Embedded Telematics Electronic Control Unit (Ecu) Production, Consumption, Export, Import by Regions (2014-2019)

Chapter Seven: Global Embedded Telematics Electronic Control Unit (Ecu) Market Status and SWOT Analysis by Regions

Chapter Eight: Competitive Landscape

Chapter Nine: Global Embedded Telematics Electronic Control Unit (Ecu) Market Analysis and Forecast by Type and Application

Chapter Ten: Embedded Telematics Electronic Control Unit (Ecu) Market Analysis and Forecast by Region

Chapter Eleven: New Project Feasibility Analysis

Chapter Twelve: Research Finding and Conclusion

Chapter Thirteen: Appendix continued

List of tables List of Tables and Figures

Figure Product Picture of Embedded Telematics Electronic Control Unit (Ecu)

Table Product Specification of Embedded Telematics Electronic Control Unit (Ecu)

Figure Market Concentration Ratio and Market Maturity Analysis of Embedded Telematics Electronic Control Unit (Ecu)

Figure Global Embedded Telematics Electronic Control Unit (Ecu) Value ($) and Growth Rate from 2014-2024

Table Different Types of Embedded Telematics Electronic Control Unit (Ecu)

Figure Global Embedded Telematics Electronic Control Unit (Ecu) Value ($) Segment by Type from 2014-2019

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 1 Picture

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 2 Picture

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 3 Picture

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 4 Picture

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 5 Picture

Table Different Applications of Embedded Telematics Electronic Control Unit (Ecu)

Figure Global Embedded Telematics Electronic Control Unit (Ecu) Value ($) Segment by Applications from 2014-2019

Figure Application 1 Picture

Figure Application 2 Picture

Figure Application 3 Picture

Figure Application 4 Picture

Figure Application 5 Picture

Table Research Regions of Embedded Telematics Electronic Control Unit (Ecu)

Figure North America Embedded Telematics Electronic Control Unit (Ecu) Production Value ($) and Growth Rate (2014-2019)

Figure Europe Embedded Telematics Electronic Control Unit (Ecu) Production Value ($) and Growth Rate (2014-2019)

Table China Embedded Telematics Electronic Control Unit (Ecu) Production Value ($) and Growth Rate (2014-2019)

Table Japan Embedded Telematics Electronic Control Unit (Ecu) Production Value ($) and Growth Rate (2014-2019) continued

About HongChun Research: HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details: Jennifer Gray Manager Global Sales + 852 8170 0792 [emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

Continue reading here:
Jennifer.grey The Daily Chronicle - The Daily Chronicle

Read the Rest...

This Is Why Your Asthma Could Be Worse in the Summer, Study Says – MSN Money

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on This Is Why Your Asthma Could Be Worse in the Summer, Study Says – MSN Money

Provided by Best Life

While asthma has long been a common childhood ailment, the number of children developing the condition in recent years is cause for concern. According to the Centers for Disease Control and Prevention (CDC), in 2001, 1 in 14 people had asthmaand as of 2009, that number was up to 1 in 12. Among black children, those rates have risen even more dramaticallyup 50 percent within the same time frame.

Fact: 25 million Americans have asthma. And while this respiratory condition is even more worrisome right now, in the midst of the coronavirus pandemic, it's also troubling because severe attacks could be triggered by the record high temperatures happening across America. New research shows that heat waves and thunderstorms that often occur during the summertime put people with asthma at additional risk.

For the study, which was published in JAMA Internal Medicine on Aug. 10, researchers compared emergency room records due to acute respiratory distress with county-wide atmospheric and lightning data between Jan. 1999 and Dec. 2012. They discovered that there was a spike in hospitalizations52,000 more, to be exactfrom seniors with asthma and chronic obstructive pulmonary disease (COPD) in the three or more days before a major storm.

"We found ER visits rose in the days leading up to the thunderstorm when temperature is rising and the amount of particulate matter in the air begins to rise," study author Anupam Jena, MD, PhD, an associate professor of health care policy at Harvard Medical School, told CNN.

This could be because particulate matterwhich are smaller than dust, dirt, and smoke particlesare dispersed faster and farther when temperatures rise and wind speed picks up before a storm. These microscopic particles can be lodged deep into the lungs, making it extremely difficult to breathe, especially among those with asthma.

"Prior studies suggest that rapid temperature increases can precipitate respiratory problems, and we observed changes in temperature in the days prior to thunderstorms," Jena explained.

RELATED: For more up-to-date information, sign up for our daily newsletter.

Heat and humidity are also known to increase mold growth and seasonal pollen, both of which are common asthma triggers. In fact, the phenomenon known as "thunderstorm asthma" dates back four decades, when asthma attacks were linked to violent thunderstorms in England and Australia.

"If you know a thunderstorm is coming, be mindful just as you would when pollen counts are high, and take a little extra care," Jena said. And for more atmospheric changes that could affect your health, This Rare Weather Event Is About to Make Coronavirus Even Worse.

Video: 1-On-1 With US Surgeon General Dr. Jerome Adams (CBS Minnesota)

1-On-1 With US Surgeon General Dr. Jerome Adams

SHARE

SHARE

TWEET

SHARE

EMAIL

Click to expand

UP NEXT

Go here to see the original:
This Is Why Your Asthma Could Be Worse in the Summer, Study Says - MSN Money

Read the Rest...

Europe Medical Keyboards Medical Mice Market Size Is Rising Tremendously Due To Increasing Need of Healthcare Services Centralization Till 2025 – My…

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Europe Medical Keyboards Medical Mice Market Size Is Rising Tremendously Due To Increasing Need of Healthcare Services Centralization Till 2025 – My…

Global Medical Keyboards Medical Mice market- Report defines the vital growth factors, opportunities and market segment of top players during the forecast period from 2020 to 2025. The report Medical Keyboards Medical Mice offers a complete market outlook and development rate during the past, present, and the forecast period, with concise study, Medical Keyboards Medical Mice market effectively defines the market value, volume, price trend, and development opportunities. The comprehensive, versatile and up-to-date information on Medical Keyboards Medical Mice market is provided in this report.

The latest research report on Medical Keyboards Medical Mice market encompasses a detailed compilation of this industry, and a creditable overview of its segmentation. In short, the study incorporates a generic overview of the Medical Keyboards Medical Mice market based on its current status and market size, in terms of volume and returns. The study also comprises a summary of important data considering the geographical terrain of the industry as well as the industry players that seem to have achieved a powerful status across the Medical Keyboards Medical Mice market.

Get Sample of this Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=121184&RequestType=Sample

Segmentations

Global Medical Keyboards Medical Mice Market: Regional Analysis The report offers in-depth assessment of the growth and other aspects of the Medical Keyboards Medical Mice market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

Segment by Type:

Keyboard Mice

Segment by application

OEMs Aftermarket

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Medical Keyboards Medical Mice Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2020.

The major players in the market iKey, Medical Grade, Seal Shield, Active Key, Sterile FLAT, Cleankeys, Keywi, Evo, Man&Machine, Baaske, InduKey, Bytec, Esterline, Wetkeys, Unotron, Athene

Do You Have Any Query Or Specific Requirement @https://brandessenceresearch.biz/Request/Sample?ResearchPostId=121184&RequestType=Methodology

Complete Analysis of the Medical Keyboards Medical Mice Market:

Comprehensive assessable analysis of the industry is provided for the period of 2020-2025 to help investors to capitalize on the essential market opportunities.

The key findings and recommendations highlight vital progressive industry trends in the global Medical Keyboards Medical Mice market, thereby allowing players to improve effective long term policies

A complete analysis of the factors that drive market evolution is provided in the report.

To analyze opportunities in the market for stakeholders by categorizing the high-growth segments of the market

The numerous opportunities in the Medical Keyboards Medical Mice market are also given.

Report Answers Following Questions:

What are the factors driving the growth of the market?

What factors are inhibiting market growth?

What are the future opportunities in the market?

Which are the most dynamic companies and what are their recent developments within the Medical Keyboards Medical Mice Market?

What key developments can be expected in the coming years?

What are the key trends observed in the market?

Full Report from Here @https://brandessenceresearch.biz/ICT-and-Media/Medical-Keyboards-Medical-Mice-Market-Professional-Survey-2019-by-Manufacturers-Regions-Countries-Types-and-Applications-Forecast-to-2024/Summary

TABLE OF CONTENT

1 Report Overview

2 Global Growth Trends

3 Market Share by Key Players

4 Breakdown Data by Type and Application

5 United States

6 Europe

7 China

8 Japan

9 Southeast Asia

10 India

11 Central & South America

12 International Players Profiles

13 Market Forecast 2020-2025

14 Analysts Viewpoints/Conclusions

15 Appendix

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at [emailprotected]

Blog: https://businessstatsnews.com

Blog: http://www.dailyindustrywatch.com

Blog: https://marketsize.biz

Blog: https://technologyindustrynews.com

Blog: https://marketstatsreport.com

Top Trending Reports:

https://northeast.newschannelnebraska.com/story/42480432/egg-powder-market-share-trends-key-players-analysis-overview-and-competitive-landscape-2020-2025-covid-19-impact-analysis

https://panhandle.newschannelnebraska.com/story/42480071/cosmetic-preservatives-market-size-overview-and-competitive-landscape-and-expected-to-reach-usd-50288-million-by-2025-with-the-cagr-of-653-bmrc

https://midplains.newschannelnebraska.com/story/42480649/agricultural-microbials-market-shares-size-vendors-and-forecasts-analysis-worldwide-expected-to-reach-usd-1188-billion-by-2025-with-a-cagr-of-142

http://www.fox21delmarva.com/story/42465746/commercial-vehicle-market-size-2020-challenges-and-opportunities-trends-and-forecasts-2025-cagr-of-663

https://www.doublet973.com/story/42465746/commercial-vehicle-market-size-2020-challenges-and-opportunities-trends-and-forecasts-2025-cagr-of-663

Excerpt from:
Europe Medical Keyboards Medical Mice Market Size Is Rising Tremendously Due To Increasing Need of Healthcare Services Centralization Till 2025 - My...

Read the Rest...

Sports Medicine Market 2020 Size, Share, Regional Growth, Trends, Methods, Applications, Equipment vendors, Business Prospects and Forecast to 2025 -…

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Sports Medicine Market 2020 Size, Share, Regional Growth, Trends, Methods, Applications, Equipment vendors, Business Prospects and Forecast to 2025 -…

The global Sports Medicine Market Report 2020 was prepared to provide the market landscape and unlimited guidelines for the current market size, market share, driving factors, Trends, progressive growth and the dominant players of the Sports Medicine Market. The report provides top manufacturers, distributors, dealers and dealers with general information about the market. It will help you to understand the product scope, the market overview, the driving force of the market, technological progress, market risk, opportunities and research results.

Our Reports on the Sports Medicine Market for the new Research Areas industrial market offer a holistic analysis, market size and forecast, Trends, growth drivers and challenges as well as a supplier analysis for about 25 suppliers.

Get sample copy of Sports Medicine Market report @ https://www.adroitmarketresearch.com/contacts/request-sample/1578

It provides a knowledge regarding Porters Five Forces including substitutes, potential entrants, buyers, industry competitors, and suppliers with genuine information for understanding the global Sports Medicine market. Furthermore, it offers detailed data of vendors including the profile, specifications of product, sales, applications, annual performance in the industry, investments, acquisitions and mergers, market size, revenue, market share, and more. The Sports Medicine market report delivers an in-depth study of market size, country-level market size, region, segmentation market growth, market share, sales analysis, value chain optimization, market players, the competitive landscape, recent developments, strategic market growth analysis, trade regulations, opportunities analysis, product launches, technological innovations, and area marketplace expanding. The Sports Medicine market reports delivers the knowledge about market competition between vendors through regional segmentation of markets in terms of revenue generation potential, business opportunities, demand & supply over the forecasted period.

Top Leading Key Players are:

Zimmer Biomet, DJO Global, Wright Group N.V., Wright Medical Group N.V. acquired Cartiva in October

Browse the complete report @ https://www.adroitmarketresearch.com/industry-reports/sports-medicine-market

The research report has drafted the report with the offerings of price, production type, acquisition & mergers, Sports Medicine market size, market share, sales analysis, value chain optimization, trade regulations, technological innovations, opportunities analysis, and market players. The report introduces the industrial chain analysis, downstream buyers, and raw material sources along with the accurate insights of Sports Medicine market dynamics. The report also offers a major microscopic view at the market and identifies the footprints of the manufacturers with the help of understanding the global revenue of vendors along with price and sales. The Sports Medicine market delivers quality data and appropriate figures with in terms of region, segmentation, and prominent players. The market report is determined to deliver relevant data about the global keyword market and help readers to find better track to invest in the Sports Medicine industry.

Global Sports Medicine market is segmented based by type, application and region.

Based on Type, the market has been segmented into:

By Product (Body Reconstruction, Body Support & Recovery Products)

Based on application, the market has been segmented into:

By Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Hip & Groin Injuries, Elbow & Wrist Injuries, Back & Spine Injuries)

The Sports Medicine market report also covers the regional segments and the market segments which is likely to have an impact on the growth of the market. The report offers an in-depth assessment of the growth and other aspects of the market in key countries including the US, Canada, Mexico, Germany, France, the UK, Russia, Italy, China, Japan, South Korea, India, Australia, Brazil, and Saudi Arabia. The competitive landscape chapter of the global market report provides key information about market players such as company overview, total revenue (financials), market potential, global presence, Sports Medicine market sales and revenue generated, market share, prices, production sites and facilities, products offered, and strategies adopted. This study provides Sports Medicine market sales, revenue and market share for each player covered in this report for a period between 2016 and 2020.

In the final section of the report on Sports Medicine Market, the dashboard view of the companies is provided, to compare the current industrial scenario and their contribution in total Sports Medicine Market. Moreover, it is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on the in-depth assessment of their capabilities and success in the Sports Medicine Market.

For Any Query on the Sports Medicine Market: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1578

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX 75204, U.S.A Phone No.: USA: +1 972-362 -8199 / +91 9665341414

See the article here:
Sports Medicine Market 2020 Size, Share, Regional Growth, Trends, Methods, Applications, Equipment vendors, Business Prospects and Forecast to 2025 -...

Read the Rest...

Sushant Singh Rajput: Here’s what you need to know about the painting that allegedly left the actor shaken – PINKVILLA

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Sushant Singh Rajput: Here’s what you need to know about the painting that allegedly left the actor shaken – PINKVILLA

Rhea Chakraborty has just revealed details of her and Sushant Singh Rajputs Italy vacation in October 2019. In her statement to officials, Rhea revealed that she saw signs of mental illness for the first time during this trip and a painting Sushant came across during the trip left the late actor shaken.

22

10

120

{{ hasAction('save', 'node', 555901) ? 'Saved' : 'Save' }}

Rhea Chakraborty has claimed that she first saw traces of mental illness in Sushant during their trip to Italy in 2019. Chakraborty recently opened up to officials and shared details of her trip with late boyfriend Sushant Singh Rajput to Italy in October 2019. Rhea revealed that the getaway had quite an impact on Sushant. The actor who had a keen interest in arts and culture was left shaken by a painting, according to Rheas revelations.

Rhea admitted that the painting had a strange effect on Rajput. After coming across the painting, Rhea recalled that Sushant was chanting mantras and looked visibly shaken. While Rhea said she tried consoling Sushant after the incident, it was never the same. Something inside Sushant had been shaken.

The painting titled--Saturn Devouring His Son resides in Museo del Prado, Madrid and is by legendary Spanish artist Francisco Goya. According to the traditional interpretation, it depicts the Greek myth of the Titan Cronus, who, fearing that he would be overthrown by one of his children, ate each one upon their birth. See a picture of the original painting for yourself below:

Coming back to Rheas statement, the VJ and actress also revealed more details on the duos stay in Italy. Chakraborty said that she and Sushant Singh Rajput were staying at a 600-year-old heritage hotel on their vacation and Sushant was blown away by the rich culture of the place. It was previously reported by India Today Television that Sushant's former domestic help Ashok claimed that the late actor's health deteriorated after he returned from the trip.

ALSO READ: Rhea Chakraborty reveals she saw signs of mental illness in Sushant Singh Rajput during their 2019 Europe trip

x Your comment has been submitted to the moderation queue

More:
Sushant Singh Rajput: Here's what you need to know about the painting that allegedly left the actor shaken - PINKVILLA

Read the Rest...

The first Virtual Microscope of the human brain, developed by Darmiyan, accurately measures Alzheimer’s-related abnormalities – PRNewswire

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on The first Virtual Microscope of the human brain, developed by Darmiyan, accurately measures Alzheimer’s-related abnormalities – PRNewswire

"Darmiyan's AI, machine learning algorithm using unique MRI microscopic voxel analysis with macroscopic input has generated a very sensitive and specific five year prognosis for patients presenting with amnestic MCI," noted Jamshid Ghajar, MD, PhD, FACS, Moghadam Family Director of Stanford Medicine Brain Performance Center. "This technology has high test-retest reliability and can be applied to any clinical grade MRI which is a very useful clinical tool to assist doctors advising patients with early memory complaints."

"Darmiyan's vision excited me because it offers a biologically-based, objective, and sensitive method for detecting changes in the brain that may first show up as subtle changes in memory and cognition and later, as neurodegenerative disease progresses, lead to more serious cognitive and functional deficits. The promise of a new tool that can give patients and their doctors a head start in planning for and possibly even heading off the advance of dementia is exactly what is needed right now, as the aging population grows larger. With the successful conclusion of this project, Darmiyan moves a step closer to delivering on this promise," said Bradley Buchsbaum, PhD, Cognitive Neuroscience Associate Professor at University of Toronto, Senior Scientist at Baycrest Institute & Rotman Research Institute, and the Principal Investigator of the Canadian arm of Darmiyan's validation project.

Validating BrainSeeon Both Clinical-grade and Research-grade Data

The current study showed that BrainSee performs with as high accuracy on clinical-grade data (from patients who present to clinics and hospitals) as it had previously performed on research-grade data (from patients who volunteer for research or clinical trials). This makes BrainSee the first cutting-edge solution that can be easily integrated in any community clinical setting around the world, not just the high-end academic institutions.

A blind retrospective analysis was previously conducted on 411 amnestic mild cognitive impairment (aMCI) patients with research-grade input data (MRI: 3D T1, T2, DTI; plus MMSE & CDR) reporting 90+% performance accuracy. In the current third-party validation study, external investigators blind-tested BrainSee on 107 new patients with clinical-grade input data (routine clinical T1, T2, DWI; plus MMSE & estimated CDR from clinician notes).

While all 107 patients held the same clinical diagnosis label of aMCI, BrainSee visualized and quantified microstructural differences that existed in each patient's brain, and predicted if they would convert to Alzheimer's dementia within 5 years (converter) or stay stable/ improve (non-converter). Investigators compared BrainSee's predictions against the actual clinical diagnosis five years later. The overall predictive accuracy of BrainSee was reported as 91% (Sensitivity 90%, Specificity 92%)."Such an accurate and non-invasive prognostic tool is non-existent in the market today," noted the US investigators.

The current study also included a separate analysis for evaluating BrainSee's test-retest reliability on 84 additional aMCI patients who were recruited to get two brain MRI scans on the same day: one clinical-grade and one research-grade. The test-retest reliability (consistency) of BrainSee was reported very high, with a correlation coefficient of 99.5%.

With this external validation data, the total number of aMCI patients tested by BrainSee has reached 602.

Novel Technological Advantages

"While reading brain PET scans at Stanford & NYU hospitals as a radiologist, I imagined the day when we could help clinicians visualize and evaluate brain health more comprehensively and objectively while posing less discomfort to patients. That day has come now and Darmiyan's BrainSee technology can finally bring clarity to the field of Alzheimer's through visualizing brain tissue microstructure for doctors. Darmiyan's Virtual Microscope technology unlocks the enormous informative potential of the currently underutilized brain MRI scans," said Darmiyan's Chief Medical and Technology Officer, Kaveh Vejdani, MD. "The huge advantage of MRI modality over PET is that it is safer (no radiation exposure), faster, more cost-efficient, non-invasive (does not require radiotracer injection), and much more widely available throughout the world."

According to Dr. Michael G. Harrington, FRCP, Scientific Director of Neuroscience, HMRI, "Objective measures such as Darmiyan's BrainSee that can predict cognitive decline are strongly needed to recognize and monitor potential therapies."

Meeting Today's Clinical Needs

Alexandra Papaioannou, MD, Executive Director, and George Ioannidis, PhD, Associate Scientific Director of GERAS Centre at HHS (both Professors of Medicine at McMaster University) noted that Darmiyan's non-invasive technology "could result in an important development in the Alzheimer's field" as it has "performed well in predicting disease progression" and can "improve clinicians' workflow and how patients are monitored."

David J. Mikulis, MD, Professor and Director of the JDMI (Joint Department of Medical Imaging) Functional Neuroimaging Research Lab, UHN, noted: "I was impressed by the potential of this breakthrough technology. All study investigators are optimistic that Darmiyan's solution will be successful providing a much needed predictor of disease progression. It may therefore fill a significant diagnostic gap highly valued by patients, clinicians, and clinical researchers."

"With the great help of our clinical trials sites in the US and Canada, we demonstrated that BrainSee can well integrate in the clinical workflow without imposing any limitations, such as specific MRI protocol, in the process of monitoring MCI patients," said Darmiyan's CEO Padideh Kamali-Zare, PhD. "These data support our vision to make BrainSee readily accessible for all people worldwide addressing the dire need for accurate diagnosis of Alzheimer's disease and prognosis of mild cognitive impairment in clinics and clinical trials. Localizing and quantifying early signs of brain cell distortion, in a way that is agnostic to specific protein-based biomarkers such as amyloid or tau, is key to understanding the disease pathology early on in its process and providing personalized treatments suitable for each Alzheimer's patient in the future."

About Darmiyan, Inc.

Darmiyan(based in San Francisco, CA) was incorporated in September 2016 and backed by Y-Combinator (YC) in Summer 2017. The Company has won numerous awards and recognitions including the TEDMED Hive Innovator in 2018 and CABHI Innovation Award in 2019. Darmiyan's most recent funding in 2020 was led by the global pharma giant Eisai with participation of YC and IT-Farm.

SOURCE Darmiyan

Home

Read more from the original source:
The first Virtual Microscope of the human brain, developed by Darmiyan, accurately measures Alzheimer's-related abnormalities - PRNewswire

Read the Rest...

Want healthier, cleaner skin? The answer could be to stop showering – Telegraph.co.uk

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Want healthier, cleaner skin? The answer could be to stop showering – Telegraph.co.uk

Since the 2016 experiment, hes begun showering again, though far less frequently than before and in a way that would likely seem unusual to the average Brit. I take short, quick showers that arent hot, he explains and uses nothing but water. It gives me a rinse, makes my hair lay down, and makes me feel like theres some divide between night and day in this pandemic time, especially. He also brushes his teeth I dont want them to rot, he points out and uses hand soap. I wash my hands because I dont want to have diseases, he says. Im deliberate about why Im doing what Im doing, and I cut out the things Ive just been doing unquestionably.

Things many of us have been doing unquestionably may mean a step away from teeth whitening kits. Teeth whitening is a great example, he says. Its very much social, and about beauty. But it doesnt actually have to do with hygiene, and it doesnt mean your teeth arent free of bacteria and you dont have an oral infection. But as with the rise and changing face of soap during the Industrial Revolution, so the rise of kits to bleach the stains from our teeth mimics the past, intertwining health and beauty together inexorably.

In the book, Hamblin explains how the use of soap was a social signifier. There was great social value in knowing you werent part of the people living next to the open sewage piles that were in London and elsewhere, he says. You were part of the washed class because you could afford soap and water. The product was expensive, and it demonstrated that you were a cut above the rest. But the Industrial Revolution changed that: now, soap could be made cheaply en masse, and was available to most people to use as a way of maintaining their hygiene and safety.

Soap manufacturers then pivoted. They needed a way to continue to sell that class of beauty, says Hamblin. They produced more expensive soaps, only for luxury purposes. Chemically it was almost an identical product, but with two different consumer entry points and supposed additional value. And so theyve continued today in the same vein: cheaper, bulk-buy soaps lack the colouring and scent that more expensive ones do. Were also bombarded with messages about added ingredients that transform the humble bar of soap into something luxe and with that comes added cost.

Showers for Hamblin have started to serve a different purpose to most people: rather than being to keep clean, they signify the start of his day. This is an odd time, and at times like this, it becomes important to do things that ground you, he explains. Whether its making your bed, eating at rigid meal times or dressing up for working from home, certain rituals are important in keeping us grounded. These markers are important to us to maintain the rhythms of how our minds and bodies are meant to function, he says.

Where he wont compromise on cleanliness is in hand washing. Hands, face, space may be the phrase of the moment, uttered by the prime minister every other breath, but the importance of soap and water isnt lost on the doctor. Its the one instance where he thinks the line between health and beauty is becoming more distinct and its thanks to the coronavirus.

The moment right now with the pandemic is very important, he says. Humans are starting to ask: What is the necessary, important hygienic practice to prevent the spread of disease and what are we doing for all the other reasons? Hamblin believes that the books release comes at a good time because the public are more receptive to rethinking their beliefs. Moments of crisis like this tend to have the effect of resetting peoples value systems, he says. Most people are probably insecure about their health, their financial status, their social systems. Its moments like this where people take stock of what really matters.

Read the original here:
Want healthier, cleaner skin? The answer could be to stop showering - Telegraph.co.uk

Read the Rest...

Novartis : receives EC approval for new Xolair indication to treat severe chronic rhinosinusitis with nasal polyps – Marketscreener.com

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Novartis : receives EC approval for new Xolair indication to treat severe chronic rhinosinusitis with nasal polyps – Marketscreener.com

Basel, August 6, 2020 - Novartis today announced that the European Commission (EC) has approved Xolair (omalizumab) as an add-on therapy with intranasal corticosteroids (INC) for the treatment of adults (18 years and above) with severe chronic rhinosinusitis with nasal polyps (CRSwNP) for whom therapy with INC does not provide adequate disease control1. Phase III studies have shown that Xolair reduces nasal polyp size (defined by Nasal Polyp Score; NPS) and improves symptoms and quality of life in patients with CRSwNP5. Xolair is the first treatment for CRSwNP specifically targeting and blocking immunoglobulin E (IgE), a key driver in the inflammatory pathway of this disease.

'People with chronic rhinosinusitis with nasal polyps can experience significant quality of life impairment as a result of their symptoms. The symptoms include long-term nasal congestion and blockage, sleep disruption and loss of smell and taste,' said Lars Ingemann, Academic Director, EUFOREA*. 'The EUFOREA* patient advisory board welcomes today's approval, which will provide an additional treatment option to patients with severe chronic rhinosinusitis with nasal polyps.'

*EUFOREA: The European Forum for Research and Education in Allergy and Airway Diseases

About Xolair (omalizumab) Xolair is the only approved anti-immunoglobulin E (IgE) antibody treatment specifically designed to target and block IgE. By reducing free IgE, down-regulating high-affinity IgE receptors and limiting mast cell degranulation, Xolair minimizes the release of mediators throughout the allergic inflammatory cascade.

An injectable prescription medicine, Xolair is approved for the treatment of moderate-to-severe or severe persistent allergic asthma in more than 100 countries, including the US since 2003 and the EU since 2005. Xolair is approved for the treatment of chronic spontaneous urticaria in over 90 countries including the EU and for chronic idiopathic urticaria (CIU), as it is known in the US and Canada. Xolair has over 1.3 million patient years of exposure. In addition, a liquid formulation of Xolair in pre-filled syringes has been approved in the EU and in more than 20 countries outside of the EU, including Canada, the US and Australia. The self-administration indication for Xolair in pre-filled syringes was also approved in the EU in 2018, and has since been approved in several other countries, including Australia, Taiwan, Argentina and Brazil. In the US, Novartis and Genentech, Inc. work together to develop and co-promote Xolair. Outside of the US, Novartis markets Xolair and records all sales and related costs.

For chronic rhinosinusitis with nasal polyps (CRSwNP), Xolair is indicated in the EU as an add-on therapy with intranasal corticosteroids (INC) for the treatment of adults (18 years and above) with severe CRSwNP for whom therapy with INC does not provide adequate disease control1.

About Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Chronic rhinosinusitis with nasal polyps (CRSwNP) impacts up to 4% of people worldwide. It is a potentially debilitating condition in adults that is characterized by inflammation of the nose and paranasal sinuses with the presence of benign inflammatory polyps (nasal polyps) on the lining of the nasal sinuses or nasal cavity, which can block normal airflow2-4. It is possible to have a single polyp or several, and the size of the polyps can vary from microscopic to several centimeters6,7.

Symptoms can include nasal blockage/obstruction, nasal congestion, nasal discharge, facial pain/pressure and reduction in, or loss of, sense of smell2,3. CRSwNP is diagnosed by a physical examination with endoscopy. The condition can be associated with asthma, cystic fibrosis and aspirin sensitivity8. It is also associated with significant morbidity and decreased health-related quality of life, with quality of life impairment9-14. Patients with CRSwNP experience significantly lower health-related quality of life than the general population, with a greater impact for patients with more severe disease, other conditions (comorbidities) or whose CRSwNP has not responded to treatment (refractory disease)12.

Currently, after standard of care intranasal corticosteroids (INC), surgery and systemic corticosteroids are the main treatments for this disease all over the world. Many patients choose them; however, they are often not effective in controlling chronic symptoms over time, due to nasal polyp regrowth. After sinus surgery, nasal polyps recur in up to 80% of people, with approximately 40% requiring at least one additional surgery9. Approximately 80% of people remain uncontrolled 3-5 years after sinus surgery15.

Disclaimer This media update contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as 'potential,' 'can,' 'will,' 'plan,' 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'seek,' 'look forward,' 'believe,' 'committed,' 'investigational,' 'pipeline,' 'launch,' or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this media update, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this media update will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this media update as of this date and does not undertake any obligation to update any forward-looking statements contained in this media update as a result of new information, future events or otherwise.

About Novartis Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews For Novartis multimedia content, please visit https://www.novartis.com/news/media-library For questions about the site or required registration, please contact [email protected]

References 1. Xolair (omalizumab). SmPC 2. Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract 2016;4(4):565-572. 3. Newton JR and Ah-See KW. A review of nasal polyposis. Ther Clin Risk Manag 2008;4(2):507-512. 4. Bachert C. Evidence-based management of nasal polyposis by intranasal corticosteroids: from the cause to the clinic. Int Arch Allergy Immunol 2011;155(4):309-321. 5. Gevaert P, Omachi TA, Corren J, et al. Efficacy and safety of omalizumab in nasal polyposis: two randomized phase III trials. J Allergy and Clin Immunol 2020. doi.org/10.1016/j.jaci.2020.05.032 [online ahead of print]. 6. Patient. Nasal Polyps [online] February 24, 2017. Available from: https://patient.info/ears-nose-throat-mouth/nasal-polyps-leaflet [Last accessed: August 2020]. 7. Johns Hopkins Medicine. Could nasal polyps be the cause of your stuffy nose? Available from: https://www.hopkinsmedicine.org/health/articles-and-answers/ask-the-expert/stuffy-nose-nasal-polyps [Last accessed: August 2020]. 8. World Allergy Organization. Nasal Polyposis: A Multifactorial disease. Available from: https://www.worldallergy.org/educational_programs/world_allergy_forum/sydney/pawankar.php [Last accessed: August 2020]. 9. Bachert C, Zhang L, Gevaert P. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis. J Allergy Clin Immunol 2015;136(6):1431-1440. 10. Erskine S, Hopkins C, Kumar N, et al. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes. Rhinology 2016;54(4):311-315. 11. Hoehle LP, Phillips KM, Bergmark RW, et al. Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life. Rhinology 2016;54(4):316-322. 12. Khan A, Huynh TMT, Vandeplas G, et al. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology 2019;57(5):343-351. 13. Naclerio R, Baroody F, Bachert C, et al. Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics. A National Institute of Allergy and Infectious Diseases workshop. J Allergy Clin Immunol Pract 2020;8(5):1532-1549.e1. 14. Ye Z, Sun L, Wang Q. A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain. Health Qual Life Outcomes 2019;17(1):57. 15. van der Veen J, Seys SF, Timmermans M, et al. Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy 2017;72(2):282-290.

# # #

Novartis Media Relations E-mail: [email protected]

Novartis Investor Relations Central investor relations line: +41 61 324 7944 E-mail: [email protected]

Continue reading here:
Novartis : receives EC approval for new Xolair indication to treat severe chronic rhinosinusitis with nasal polyps - Marketscreener.com

Read the Rest...

Healthcare Nanotechnology (Nanomedicine) Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and…

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Healthcare Nanotechnology (Nanomedicine) Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and…

New Jersey, United States,- The most recent Healthcare Nanotechnology (Nanomedicine) Market Research study includes some significant activities of the current market size for the worldwide Healthcare Nanotechnology (Nanomedicine) market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Healthcare Nanotechnology (Nanomedicine) business status, presents volume and worth, key market, product type, consumers, regions, and key players.

The COVID-19 pandemic has disrupted lives and is challenging the business landscape globally. Pre and Post COVID-19 market outlook is covered in this report. This is the most recent report, covering the current economic situation after the COVID-19 outbreak.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Healthcare Nanotechnology (Nanomedicine) market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Healthcare Nanotechnology (Nanomedicine) Market, By Type

Healthcare Nanotechnology (Nanomedicine) Market, By Application

Other important inclusions in the Healthcare Nanotechnology (Nanomedicine) market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Packaging Robot Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Packtech Textiles Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Paclitaxel-eluting Stent Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Paint Pigments Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Paintball Gun Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Originally posted here:
Healthcare Nanotechnology (Nanomedicine) Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and...

Read the Rest...

Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – Good Night, Good Hockey

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – Good Night, Good Hockey

Nanomedicine Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/39223

Nanomedicine is an application of nanotechnology, which are used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine usages nanoscale manipulation of materials to improve medicine delivery. Therefore, nanomedicine has facilitated the treatment against various diseases. The nanomedicine market includes products that are nanoformulations of the existing drugs and new drugs or are nanobiomaterials. The research and development of new devices as well as the diagnostics will become, more effective, enabling faster response and the ability to treat new diseases are likely to boost the market growth.

The nanomedicine markets are driven by factors such as developing new technologies for drug delivery, increase acceptance of nanomedicine across varied applications, rise in government support and funding, the growing need for therapies that have fewer side effects and cost-effective. However, long approval process and risks associated with nanomedicine (environmental impacts) are hampering the market growth at the global level. An increase in the out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are likely to create lucrative opportunities in the nanomedicine market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nanomedicine Market Segmentation Analysis: Based on the application, the nanomedicine market has been segmented into cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. The oncology segment held the dominant market share in 2018 and is projected to maintain its leading position throughout the forecast period owing to the rising availability of patient information and technological advancements. However, the cardiovascular and neurology segment is projected to grow at the highest CAGR of XX% during the forecast period due to presence of opportunities such as demand for specific therapeutic nanovectors, nanostructured stents, and implants for tissue regeneration.

Nanomedicine Market Regional Analysis: Geographically, the Nanomedicine market has been segmented into North America, the Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the Nanomedicine market in 2018 due to the rising presence of patented nanomedicine products, the availability of advanced healthcare infrastructure and the rapid acceptance of nanomedicine. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period thanks to rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, the rising investments in research and development activities for the introduction of advanced therapies and drugs are predicted to accelerate the growth of this region in the near future.

Nanomedicine Market Competitive landscape Major Key players operating in this market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc, and Johnson & Johnson. Manufacturers in the nanomedicine are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

The objective of the report is to present a comprehensive analysis of Nanomedicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Nanomedicine Market dynamics, structure by analyzing the market segments and project the Nanomedicine Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Nanomedicine Market make the report investors guide. Scope of the Nanomedicine Market:

Nanomedicine Market by Modality:

Diagnostics Treatments Nanomedicine Market by Diseases:

Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases Ophthalmological Diseases Immunological Diseases Nanomedicine Market by Application:

Neurology Cardiovascular Anti-Inflammatory Anti-Infectives Oncology Nanomedicine Market by Region:

Asia Pacific North America Europe Latin America Middle East Africa Nanomedicine Market Major Players:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc Johnson & Johnson Mallinckrodt plc. Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Cytimmune Sciences, Inc.

Browse Full Report with Facts and Figures Report at:https://www.maximizemarketresearch.com/market-report/nanomedicine-market/39223/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Read more:
Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region - Good Night, Good Hockey

Read the Rest...

Nanomedicine Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast to 2027 – Owned

§ August 10th, 2020 § Filed under Nano Medicine Comments Off on Nanomedicine Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast to 2027 – Owned

New Jersey, United States,- The most recent Nanomedicine Market Research study includes some significant activities of the current market size for the worldwide Nanomedicine market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Nanomedicine business status, presents volume and worth, key market, product type, consumers, regions, and key players.

The COVID-19 pandemic has disrupted lives and is challenging the business landscape globally. Pre and Post COVID-19 market outlook is covered in this report. This is the most recent report, covering the current economic situation after the COVID-19 outbreak.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Nanomedicine market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Nanomedicine Market, By Type

Nanomedicine Market, By Application

Other important inclusions in the Nanomedicine market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Surgical Robots Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Hypoallergenic Infant Formula (CMPA) Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Industrial Vision Systems Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Water Quality Monitoring Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Crystal Oscillators Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See the original post:
Nanomedicine Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast to 2027 - Owned

Read the Rest...

How can nanomedicine be applied to cannabis? – Leafly

§ August 10th, 2020 § Filed under Nano Medicine Comments Off on How can nanomedicine be applied to cannabis? – Leafly

Imagine a world in which a tiny nanorobot could deliver a specific cannabinoid directly to your endocannabinoid (ECS) receptors. The nanorobot would be thousands of times smaller than the breadth of a human hair and could carry its small cargo inside a single droplet of liquid to deliver it directly to a target cell such as a cancer cell.

Sound far-fetched? It may be closer than you think, because researchers are making great strides in the fascinating field of nanomedicine.

The cannabis plant contains an amazing group of cannabinoids, terpenes, and flavonoids, and scientists are only beginning to unlock the complex pharmacology and potential of these compounds. Combined with nanomedicine, cannabis has even more potential to treat disease and provide overall health benefits for people.

Scientists can manipulate substances on an atomic scale, in the range of 1-100 nanometers, or one thousand times thinner than a sheet of paper. According to the US Nanotechnology Initiative, substances on the nanoscale have very different properties than bulk substances dounique properties like better electrical conductance, higher strength, and different magnetic properties, light reflection, or chemical reactivity. Nanotechnology can be performed on solids, liquids, or gases to unlock these unique phenomena.

For these reason, nanotechnology applications in medicine offer exciting promise and possibilities, especially when applied to cannabis compounds. Many nanotechnology applications are already in usecomputer circuits made from carbon nanotubes allow for far greater computing power, and nanoparticles are already being used in pharmaceuticals to improve absorption.

Researchers work on all kinds of aspects of nanotechnology, such as finding the best substance for nanoparticles, the best shape for a nanoparticle for a specific delivery, and the best transfer mechanisms for specific drugs. Nanoparticles can generate heat, deliver stem cells, be radioactive or metallic, and so much more.

While many applications are still only imagined by scientists, at its full potential, nanotechnology could be the next medical revolution, vastly changing how diseases are detected and treated.

One of the best applications of nanomedicine is in the area of drug delivery, whereby nanoparticles deliver substances directly to specific cells, like diseased cancer cells. Researchers can engineer nanoparticles to be attracted to a diseased cell and limit the ability to bind with and therefore damage healthy cells.

Scientists at MIT and other institutions have successfully used specific nanoparticles to deliver drugs to tumors. Even more interesting is that nanoparticles are developed to work togetherwhile one locates a tumor, another can use the signal from the first to effectively carry the drug to its intended target.

In one interesting application, scientists have created a nanoparticle that looks for hydrogen peroxide present in inflamed tissue, then it releases a drug in that environment to target heart disease.

There is great promise that nanotechnology and cannabinoids can make an impact on diseases like cancer, multiple sclerosis, Parkinsons, diabetes, and a wide range of serious inflammatory diseases.

Nanotechnology can help identify a disease at an early stage, perhaps even when a single cell has gone awry, and then deliver a targeted cannabinoid to correct a cells behavior, thus stopping the disease in its tracks. It may even be possible for a nanorobot to target a specific endocannabinoid receptor to shut down the entire inflammatory process for the betterment of a patient.

Cannabinoid nanodelivery systems have entered the research mainstream, with scientists working on biologically engineered cannabinoids and other nanoparticles to be transported to cells, and by creating nanocarrier transport substances out of metallics or other substances.

Delivery system research also touches on improving bioavailabilitythe rate at which the active substance of a drug enters the bloodstreamas well as improving the physical stability of nanoparticles and optimizing routes of administration, including injection, pills, or sublingual drops.

A nanotechnology-based targeted drug delivery system can be formulated to deliver cannabinoids directly to endocannabinoid receptors, where the magic happens. Cannabinoids can be packed inside a nanoparticle and carried to its intended target without degradation and with a controlled release.

For example, nanoemulsions are already used in the food industry to deliver probiotics or other bioactive ingredients in a very controlled release. These nanoemulsions use a combination of two liquids that dont normally combinesuch as oil and waterto serve as a barrier to chemical degradation for the cannabinoid while on its journey through the body.

Other encapsulation methods can help with potency issues by increasing absorption, they can help decrease side effects, and they can help cover a substances bitter taste.

Specific cannabis strains could even have tailored therapeutic profiles, and cannabinoids could be bioengineered to produce enhanced effects.

Scientists envision a superclass of cannabinoid nanocarriers that have potential to treat a wide array of endocannabinoid insufficiency issues and thus a wide variety of diseases.

In one example, researchers are looking at novel ways to deliver substances across the difficult blood-brain barrier. This barrier is the bodys built-in defense mechanism to protect the brain, so the ability to transport substances across it directly affects a treatments efficacy.

To this end, scientists are engineering lipid nanocapsules decorated with minute cannabinoids like CBD as novel therapies for diseases of the central nervous system.

Nanotechnology has already transformed drug delivery in profound ways, and cannabinoid delivery is part of this exciting future. There are challenges, of course. Cannabinoids quickly degrade in water and are susceptible to other kinds of degradation, and that presents delivery issues.

More recent discoveries, including the decoding of the cannabis genome, discovery of the main CB1R and CB2R receptors within the human endocannabinoid system (ECS), and discovery of other receptors, are also foundational efforts that contribute to cannabinoid nanotechnology.

The latest research shows great progress in the formulation of targeted cannabinoid-nanocarrier delivery systems, and as such may provide key therapies particularly for central nervous system disorders. As scientists continue to make improvements in both bio-efficacy and bioavailability, cannabis nanotechnology represents an exciting and brave new world.

Read the original:
How can nanomedicine be applied to cannabis? - Leafly

Read the Rest...

Global Healthcare Nanotechnology (Nanomedicine) Industry Outlook 2020-2027 with Profiles of 46 Players Including Abbott Labs, Celgene Corp, GE…

§ August 10th, 2020 § Filed under Nano Medicine Comments Off on Global Healthcare Nanotechnology (Nanomedicine) Industry Outlook 2020-2027 with Profiles of 46 Players Including Abbott Labs, Celgene Corp, GE…

DUBLIN, Aug. 5, 2020 /PRNewswire/ -- The "Healthcare Nanotechnology (Nanomedicine) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to this 9th edition of the report. The 190-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Healthcare Nanotechnology (Nanomedicine) Market to Reach $475.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Healthcare Nanotechnology (Nanomedicine) estimated at US$183.9 Billion in the year 2020, is projected to reach a revised size of US$475.2 Billion by 2027, growing at a CAGR of 14.5% over the analysis period 2020-2027.

Therapeutics, one of the segments analyzed in the report, is projected to record a 14.1% CAGR and reach US$369.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Regenerative medicine segment is readjusted to a revised 15.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $54.3 Billion, While China is Forecast to Grow at 14% CAGR

The Healthcare Nanotechnology (Nanomedicine) market in the U.S. is estimated at US$54.3 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$82.8 Billion by the year 2027 trailing a CAGR of 14% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.8% and 12.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

In-vitro diagnostics Segment to Record 16.3% CAGR

In the global In-vitro diagnostics segment, USA, Canada, Japan, China and Europe will drive the 16.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.7 Billion in the year 2020 will reach a projected size of US$16.2 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$56.9 Billion by the year 2027.

Competitors identified in this market include, among others:

Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/44bvip

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

See the original post:
Global Healthcare Nanotechnology (Nanomedicine) Industry Outlook 2020-2027 with Profiles of 46 Players Including Abbott Labs, Celgene Corp, GE...

Read the Rest...

Global Projection 2020: Nanomedicine Market Exclusive Profitable Comprehensive Research Report with COVID-19 Impact Overview | Forecast 2029 – News…

§ August 10th, 2020 § Filed under Nano Medicine Comments Off on Global Projection 2020: Nanomedicine Market Exclusive Profitable Comprehensive Research Report with COVID-19 Impact Overview | Forecast 2029 – News…

An investigation ofNanomedicineMarket has been given in the most recent report launched by MarketResearch.Biz that essentially focuses on the market trends, demand spectrum, and future prospects of this industry over the conjecture time frame. Moreover, the report gives a point by point statistical review in terms of trends outlining the geographical opportunities and contributions by prominent industry share contenders.

In addition, the report centers on giving thorough comprehensive analytical data on the local fragments, which incorporate North America, Asia-Pacific, Middle East & Africa, and the Rest of the World. Other than this, improvement plans and strategies, marketing terminologies, manufacturing protocols, current trends, dynamics of the market, and characterization have been clarified in brief in this Nanomedicine market report. The group of specialists and investigators displays the readers exact measurements and logical information in the report in a simple manner by methods for graphs, outlines, pie graphs, and other pictorial delineations.

For all-inclusive information: Download a FREE sample copy of NanomedicineMarket Report Study 2020-2029 athttps://marketresearch.biz/report/nanomedicine-market/request-sample

Topmost Prime Key Manufacturers of Nanomedicine Market Report-Abbott Laboratories, Ablynx NV, Abraxis BioScience, Inc., Celgene Corporation, Teva Pharmaceutical Industries Limited, GE Healthcare Limited, Merck & Co., Inc., Pfizer Inc., Nanosphere, Inc., Johnson & Johnson Services, Inc.

How Does This Nanomedicine Market Insights Help?

Nanomedicine Market share (regional, product, end-user, application) both in terms of volume and revenue alongside CAGR

Key parameters which are driving this market and restraining its development

What all challenges manufacturers will face as well as new opportunities and threats faced by them

Find out about the market strategies that are being adopted by your competitors and leading organizations

To gain insightful analyses of the market and have a extensive comprehension of the Nanomedicine Market and its commercial landscape

Impact of Covid-19 in Nanomedicine Market:The utility-possessed section is for the most part being driven by increasing financial incentives and regulatory supports from the governments globally. The current utility-owned Nanomedicine are affected primarily by the COVID-19 pandemic. Most of the projects in China, Germany, the US, and South Korea are delayed, and the companies are facing short-term operational issues due to supply chain constraints and lack of site access due to the COVID-19 outbreak. Asia-Pacific is anticipated is foreseen to get exceptionally influenced by the spread of the COVID-19 due to the effect of the pandemic in China, Japan, and India. China is the epic focus of this lethal disease.

Connect with our Analyst to understand the CORONA Virus/COVID-19 impact and be smart in redefining Business Strategies @https://marketresearch.biz/report/nanomedicine-market/covid-19-impact

Overview of Nanomedicine market:

The report begins with a market overview and moves on to cover the growth prospects of the Nanomedicine market. A detailed segmentation analysis of the Nanomedicine market is available in the report. Nanomedicine industry comprehensive analysis also covers upstream raw materials, marketing channels, downstream client surveys, equipment, industry development trend, and proposals. Furthermore, a business overview, revenue share, and SWOT analysis of the leading players in the Nanomedicine market are available in the report.

Click on- >To Inquiry And Customization of Nanomedicine Market Report

Segmentation Assessment By product, application, and region:

Global nanomedicine market segmentation by product: Therapeutics Regenerative medicine In-vitro diagnostics In-vivo diagnostics Vaccines

Global nanomedicine market segmentation by application: Clinical Oncology Infectious diseases Clinical Cardiology Orthopedics Others

The report offers an in-depth assessment of growth and other aspects of the market. Nanomedicine in major countries (regions), including:

> North America (United States, Canada and Mexico)

> Europe (Germany, France, United Kingdom, Russia and Italy)

> Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

> South America (Brazil, Argentina, etc.)

> Middle East and Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

In this study, the years considered to estimate the market size of the Nanomedicine Market are as follows:

Base Year: 2019 | Estimated Year: 2020 | Forecast Year: 2020 to 2029

Nanomedicine industrial report not only offers hard to find facts about the trends and innovation driving the current and future of Nanomedicine business, but also provides insights into competitive development such as acquisition and mergers, joint ventures, product launches, and technology advancements.

Table of Contents

Introduction: The report begins with an executive summary, which includes the highlights of the Nanomedicine Industry Research Study.

Market Segmentation: This section provides a detailed analysis of the type and application segments of the Nanomedicine market and shows the progress of each segment with the help of easy-to-understand statistics and graphical presentations.

Regional Analysis: All major regions and countries are covered in the Nanomedicine Industry Report.

Market Dynamics: The report provides an insight into the dynamics of the Nanomedicine industry, including challenges, constraints, trends, opportunities, and drivers.

Competition: Here, the report provides company profiles of the top players competing in the Nanomedicine market.

Forecasts: This section is filled with global and regional forecasts, CAGR, and size estimates for the Nanomedicine market and its segments, and production, revenue, consumption, sales, and other forecasts.

Recommendations: The authors of the report have provided practical suggestions and reliable recommendations to help players achieve a position of strength in the Nanomedicine market.

Research Methodology: The report provides clear information about the research approach, tools and methodology, and data sources used for the Nanomedicine Industry Research Study.

>>>Read Out Complete TOC of Nanomedicine Market@https://marketresearch.biz/report/nanomedicine-market/#toc<<<

About Us

MarketResearch.biz is a global market research and consulting service provider specialized in offering a wide range of business solutions to their clients including market research reports, primary and secondary research, demand forecasting services, focus group analysis and other services. We understand that how data is important in todays competitive environment and thus, we have collaborated with industrys leading research providers who work continuously to meet the ever-growing demand for market research reports throughout the year.

Contact Us:

Mr. Benni Johnson (inquiry@marketresearch.biz)

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Website:https://marketresearch.biz

Share Your Questions Here For More Details On this Report or Customizations As Per Your Need:https://marketresearch.biz/report/nanomedicine-market/#request-for-customization

The rest is here:
Global Projection 2020: Nanomedicine Market Exclusive Profitable Comprehensive Research Report with COVID-19 Impact Overview | Forecast 2029 - News...

Read the Rest...

Green One-Step Synthesis of Medical Nanoagents for Advanced Radiation | NSA – Dove Medical Press

§ August 10th, 2020 § Filed under Nano Medicine Comments Off on Green One-Step Synthesis of Medical Nanoagents for Advanced Radiation | NSA – Dove Medical Press

Daniela Salado-Leza,1,2 Erika Porcel,1 Xiaomin Yang,1 Lenka tefankov,1 Marta Bolsa-Ferruz,1 Farah Savina,1 Diana Dragoe,3 Jean-Luc Guerquin-Kern,4 Ting-Di Wu,4 Ryoichi Hirayama,5 Hynd Remita,6 Sandrine Lacombe1

1Universit Paris Saclay, CNRS UMR 8214, Institut des Sciences Molculaires dOrsay, 91405 Orsay, France; 2Ctedra CONACyT, Faculty of Chemical Sciences, Autonomous University of San Luis Potos, 78210 San Luis Potos, Mexico; 3Universit Paris Saclay, CNRS UMR 8182, Institut de Chimie Molculaire et des Matriaux dOrsay, 91405 Orsay, France; 4Paris-Saclay University, Multimodal Imaging Center (UMS 2016/US 43) CNRS, INSERM, Institut Curie, 91405 Orsay, France; 5Department of Charged Particle Therapy Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 263-8555 Chiba, Japan; 6Universit Paris Saclay, CNRS UMR 8000, Institut de Chimie Physique, 91405 Orsay, France

Correspondence: Sandrine Lacombe Universit Paris-Saclay, CNRS UMR 8214, Institut des Sciences Molculaires dOrsay, Andr Rivire Street, Building 520, Orsay Cedex 91405, France Tel +33 1 6915 8263 Email sandrine.lacombe@universite-paris-saclay.fr

Purpose: Metal-based nanoparticles (M-NPs) have attracted great attention in nanomedicine due to their capacity to amplify and improve the tumor targeting of medical beams. However, their simple, efficient, high-yield and reproducible production remains a challenge. Currently, M-NPs are mainly synthesized by chemical methods or radiolysis using toxic reactants. The waste of time, loss of material and potential environmental hazards are major limitations. Materials and Methods: This work proposes a simple, fast and green strategy to synthesize small, non-toxic and stable NPs in water with a 100% production rate. Ionizing radiation is used to simultaneously synthesize and sterilize the containing NPs solutions. The synthesis of platinum nanoparticles (Pt NPs) coated with biocompatible poly(ethylene glycol) ligands (PEG) is presented as proof of concept. The physicochemical properties of NPs were studied by complementary specialized techniques. Their toxicity and radio-enhancing properties were evaluated in a cancerous in vitro model. Using plasmid nanoprobes, we investigated the elementary mechanisms underpinning radio-enhancement. Results and Discussion: Pt NPs showed nearly spherical-like shapes and an average hydrodynamic diameter of 9 nm. NPs are zero-valent platinum successfully coated with PEG. They were found non-toxic and have the singular property of amplifying cell killing induced by -rays (14%) and even more, the effects of carbon ions (44%) used in particle therapy. They induce nanosized-molecular damage, which is a major finding to potentially implement this protocol in treatment planning simulations. Conclusion: This new eco-friendly, fast and simple proposed method opens a new era of engineering water-soluble biocompatible NPs and boosts the development of NP-aided radiation therapies.

Keywords: platinum nanoparticles, radiolytic method, environmentally-friendly process, nanomedicine, radiotherapy

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Excerpt from:
Green One-Step Synthesis of Medical Nanoagents for Advanced Radiation | NSA - Dove Medical Press

Read the Rest...

Can the AC filter in your home, office or local mall protect you from Covid-19? – FOX10 News

§ July 8th, 2020 § Filed under Nano Medicine Comments Off on Can the AC filter in your home, office or local mall protect you from Covid-19? – FOX10 News

When New York Governor Andrew Cuomo announced last week that malls in New York could not reopen until they installed high-efficiency particulate air filters capable of trapping the virus that causes Covid-19, Harvard environmental health researcher Joseph Gardner Allen was thrilled.

"I've been writing consistently since early February about how healthy buildings should be the first line of defense against the novel coronavirus," said Allen, who directs the Healthy Buildings program at the Harvard T.H. Chan School of Public Health.

"I'm really grateful that we have a leader in the country -- somewhere -- who was finally talking about healthy buildings, ventilation and filtration," Allen said. "That hasn't happened before. It just hasn't happened."

Allen was one of 239 scientists who wrote an open letter to the World Health Organization, the US Centers for Disease Control and Prevention and other health agencies, asking for a change in their guidance to the public on how the novel coronavirus, or SARS-CoV-2, can spread.

Current guidance only focuses on "hand washing, maintaining social distancing, and droplet precautions," according to the letter, published Monday in the journal Clinical Infectious Diseases.

The health agencies are ignoring the tiny droplets of virus that sputter and spray from our mouths, become aerosolized and then float away into the air, the scientists said, as a likely means of transmission.

"They don't want to talk about airborne transmission because that is going to make people afraid," co-author Donald Milton, a professor of environmental health at the University of Maryland, told CNN in a prior interview.

"The best vaccine against fear is knowledge and empowering people to take care of themselves," Milton said. "Why wearing a mask is important is because it blocks the aerosols at their source, when it is easy to block them."

Because the CDC and WHO "have been so slow to acknowledge aerosol transmission is happening, buildings are not putting in appropriate control measures," said Allen, who has focused his career on "sick buildings" and how they affect worker performance and productivity.

"The prudent and pragmatic approach is to acknowledge that airborne transmission is happening and put in the controls. If we find out in five years, that airborne was 5% of transmission, then OK," Allen said. "But what if it's 20% or 30% and we failed to acknowledge it? That's a problem."

During a press briefing on Tuesday, WHO Technical Lead for Infection Prevention and Control, Dr. Benedetta Alleganzi, said the agency has discussed and collaborated with many of the scientists who signed the letter.

"We acknowledge that there is emerging evidence in this field," Alleganzi said. "Therefore we believe that we have to be open to this evidence and understand its implications regarding the modes of transmission and also regarding the precautions that need to be taken."

Alleganzi also emphasized that emerging evidence is not yet conclusive.

"The possibility of airborne transmission in public settings, especially in very specific conditions crowded, closed, poorly ventilated settings ... cannot be ruled out," she said. "However, the evidence needs to be gathered and interpreted."

Currently the CDC says "Covid-19 is thought to spread mainly through close contact from person-to-person," through "respiratory droplets produced when an infected person coughs, sneezes, or talks."

"I subscribe to the CDC opinion that the vast majority of transmission occurs within 3 to 6 feet from the infected person. That's the highway where all the traffic is -- where the the vast majority of this virus is transmitted," said infectious disease expert Dr. William Schaffner, a professor of preventive medicine and infectious diseases at Vanderbilt University School of Medicine in Nashville.

"Are there side streets where it can become an aerosol and spread into the air? Yes," Schaffner said, adding that isn't likely to create a significant transmission route. If future public health investigations find these "aerosol transmission events are more common than currently thought," that could change priorities.

"But I don't think we need to change all the AC units in the US and around the world based on side street traffic," Schaffner added. "We want to attack the high traffic route by the big three -- masks, social distancing and avoiding large groups. Then we'll get virus transmission down."

A mid-March study found SARS-CoV-2 can survive in microscopic respiratory droplets about 2.5 microns in diameter and smaller, which can remain airborne and viable for up to three hours or more.

In early May, Harvard's Allen and Linsey Marr, a professor of civil and environmental engineering at Virginia Tech, published a paper that rounded up research focusing on the role of smaller airborne particles in the spread of the novel coronavirus.

"It is impossible for someone to release 'large droplets' (>5 microns) without also releasing smaller ones. Thus, transmission that is purported to occur via the spray of large droplets from a cough could in fact be occurring through inhalation of much smaller droplets at close range," the paper said.

Marr, who made a groundbreaking discovery that flu virus could float in the air in microscopic droplets for an hour or more, likes to use cigarettes as a way to explain how viruses spread.

"The smaller microscopic ones that we call aerosols behave kind of like cigarette smoke. So they're going to be more concentrated closer to the smoker, the person who might be infected. As you get farther away, your exposure would be much less," Marr said.

Will masks protect against those microscopic floating droplets? Top-rated N95 and surgical-grade masks will, and scientists are scrambling to study and tweak the effectiveness of homemade masks.

"For most cloth face masks, there is no inner filtration layer that traps harmful particles," said Sara Greenstein, president and CEO of Lydall, one of the companies who signed with the U.S. Department of Defense to produce filtration media for N95 masks.

"Although wearing a cloth face mask is better than nothing, it is no substitute for an N95 or surgical mask, which are precisely engineered, highly technical products," Greenstein said.

Even when medical-grade masks are widespread, ventilation systems with highly effective filters are another key way to filter droplets from the air, Allen said.

In his edict to New York mall owners, Cuomo was talking about HEPA filters, which have the highest MERV ratings, between 17 and 20.

What's MERV? It stands for "minimum efficiency reporting value," and it's how filters are rated in their ability to trap tiny particles. The MERV ratings go from one to 20: Filters with higher MERV ratings are more effective than filters with lower ratings.

At the highest end, HEPA filters are used by hospitals to create sterile rooms for surgeries and to control infectious diseases, and are able to remove 99.97% of dust, pollen, mold, bacteria and other airborne particles with a size as small as 0.3 microns. For comparison, Covid-19 is thought to be between 0.06 to 1.4 microns.

"Filters are rated at their worst performance, so 99.97% is the worst it will do," Allen said. "And that's rated for a particle size of 0.3 microns, but smaller and larger it actually does better. So the point is that it's capturing nearly all particles."

Unfortunately, most businesses and home owners may find it difficult to retrofit their existing system to accommodate a HEPA filter, or any filter higher than the rating recommended by the system's manufacturer.

Doing so can actually impair the system's performance: Smaller pores in HEPA air filters make it more difficult for it to push air. Using denser filters can affect the efficiency of the unit and strain the fan, while decreasing indoor air quality -- the opposite of what you desire.

"HEPA filtration is not always going to be feasible or practical," Allen said. "But there are other filters that can do the job. What is recommended now by the standard setting body for HVAC is a MERV 13 filter."

High-efficiency filters in the 13-to-16 MERV range are often used in hospitals, nursing homes, research labs and other places where filtration is important.

"If you're an owner of a home, building or mall, you want to have someone to assess your system and install the largest MERV number filter the system can reliably handle without dropping the volume of air that runs through it," advised Erin Bromage, an associate professor of biology at the University of Massachusetts Dartmouth.

"In addition, virtually all modern air conditioning systems in commercial buildings have a process called makeup air where they bring in air from outside and condition it and bring it inside," said Bromage, a CNN contributor who wrote a blog post in early May -- "The Risks -- Know Them -- Avoid Them," that got over 13 million views in one week.

Building owners should be looking at increasing the amount of makeup air that is brought inside by opening dampers, Bromage suggested.

"It's worse in regards to energy, but the more outside air we bring in, the more dilution of the virus we have and then the safer you are," Bromage said, adding that it's important to also monitor humidity levels."

"There's sort of a 'Goldilocks' zone for the coronavirus, between 40 and 60% humidity, where it doesn't survive for very long," Bromage said.

Below 40% humidity, he said, the infected droplets hang in the air longer, thus providing the opportunity to travel farther to infect people.

"Above 60%, the droplets lose moisture more slowly, and therefore are heavier and more vulnerable to gravity," Bromage said, "which sounds like a great thing."

"But it actually drops onto surfaces much faster and being wet actually keeps the virus alive and infectious for longer," he added.

First, focus on following public health recommendations: Wear masks when you go outside, stay away from large crowds and 6 feet from anyone not in your "quarantine bubble," wash your hands with soap frequently, keep your hands away from your face, and try to only go to outdoor locations with excellent air circulation and filtration.

If you have the resources, there are also personal HEPA air purifiers on the market, designed to clean a standard room of a home. Some even come with humidifiers that will measure the air and keep the room between 40% and 60%, while others incorporate UV light technology designed to kill stray particles.

"Properly balanced UV light will inactivate viruses and bacteria in the air, which just adds an extra layer to the protection coming from the air purifier," Bromage said.

Costs range from a few hundred to over a thousand dollars, but don't be fooled by the price tag: You're looking for a machine with a HEPA filter designed for the size of your room -- so measure carefully. Having too small of a machine in a large room won't clean the air -- while having a large system in a small room is a waste of money.

Finally, know that HEPA filters can be pricey and will need frequent attention to keep them in top performance.

Many point to the cost of filters and the expense of retrofitting buildings and say it may not be worth it. That's not always the case, Allen said.

"It's a total misnomer that healthy building strategies and higher ventilation rates and filtration are expensive strategies," Allen said. "When people know and understand how it's transmitted, then they're empowered to make better decisions.

"And that includes right in your home: You'd have people over, open up those windows; you're in your car with somebody else, roll down the window, a few inches," Allen said.

"No one strategy alone is going to work. But if we layer enough of these on top of each other, we can significantly reduce risks."

CNN's Shelby Erdman contributed to this story. Correction: An earlier version of this story miscounted the authors of the letter to the WHO and CDC. Clarification: An earlier version of this story included an explanation from Erin Bromage about moisture levels in droplets that he clarified with a new quote.

We are back into the triple digits in Mobile County in the number of COVID-19 cases reported.

COVID-19 could be having another dangerous effect in Mobile.

Stanford announced Wednesday that it is dropping 11 sports amid financial difficulties cause

The novel coronavirus pandemic could lead to a wave of brain damage in infected patients, wa

Alabama Gov. Kay Ivey on Wednesday announced the Revive Alabama grant program to support sma

President Donald Trump on Wednesday threatened to withhold federal funding if schools dont

After President Donald Trump tweeted Wednesday that he disagreed with US Centers for Disease

TheGulf Coast Hot Air Balloon Festival for this year has been canceled due to COVID-19 concerns.

Harvard and the Massachusetts Institute of Technology on Wednesday sued the Trump administra

Six months ago, no one thought Covid-19 existed in the US.

Success! An email has been sent to with a link to confirm list signup.

Error! There was an error processing your request.

Follow this link:
Can the AC filter in your home, office or local mall protect you from Covid-19? - FOX10 News

Read the Rest...

Masks: To wear or not to wear? – South Alabamian

§ July 8th, 2020 § Filed under Nano Medicine Comments Off on Masks: To wear or not to wear? – South Alabamian

I had the good fortune of nearly losing a friend to coronavirus.

My friend went through the full treatment, ICU, ventilator, everything, and lived to tell the tale.

While he fought, his friends and loved ones hoped, suffered and prayed. Many of us also vowed to take COVID- 19 seriously. If it could hit him so hard, nothing was stopping it from tiptoeing through our lives like a horde of hippos in tutus.

Our family has taken the conservative approach of wearing masks and social distancing whenever necessary. It goes back to basic germ theory thats been around for hundreds of years.

Our ancestors discovered that many of their illnesses were caused by microscopic organisms floating in the air. My mask captures tiny droplets of water from my nose and mouth that would have otherwise escaped. Your mask does the same, so we keep potential illnesses to ourselves.

Thats the theory behind doctors and nurses wearing masks all day in operating rooms.

Since COVID- 19 hit the scene, Ive heard a lot about PPE, which is personal protective equipment. I thought it was limited to medicine, but then I called a friend who is a veteran with decades of military service.

Hes more worried about this illness than any time spent in a war zone. His health issues combined with COVID could be deadly, and hes concerned that his fellow citizens arent taking masks as seriously as they should.

He was at a gathering of farflung family, and everyone was sitting away from each other and wearing masks. Then a relative came in without a mask and wanted to hug my friends young niece.

When the others stopped him, the newcomer said, If I get it, I get it.

Its a common sentiment. Ive heard it from a bunch of people on Facebook, Twitter and TV.

When I was in Afghanistan, I never took off my PPE, waved my hands and said, If the Taliban gets me, they get me, my friend said.

I like to steer clear of politics when Im writing. Its not because I dont have strong opinions; its because Ive learned a thing or two about human nature over the years.

Peoples politics are deeply held parts of their identities. Thats true for me and, Ive found, most everybody else.

If I were to attack your favorite politician, you wouldnt consider the logic of my argument because you would be too invested in your argument.

Im not picking on you. I would feel the same way. If you want me to pay attention, dont slam my deeply held beliefs.

But our identities are complex.

I know a lot of people who have different views on politics than I have, but theyre still my friends. In fact, anytime I actually do reconsider my political views is because of them: Theyre good people, so how come theyre so wrong? Is it me?

Usually, its them, but I digress.

The wearing of a mask and social distancing is not about politics. Its about protecting friends and family. Its about protecting teammates and fellow citizens. And, really, its about protecting ourselves.

My friend who had COVID- 19 didnt fight his way through the ICU so he could be an object lesson. He simply did what it took to survive.

My friend who served in Afghanistan didnt wear PPE to teach us any lessons either.

Still, wed be wise to learn from them both during these so very strange days.

M. Scott Morris is a former editor of The South Alabamian.

Hes an English teacher living in Tupelo, Mississippi.

Read more from the original source:
Masks: To wear or not to wear? - South Alabamian

Read the Rest...

Latest Research on Nanomedicine Market 2020 by Application, Industry Share, End User with top players GE Healthcare, Johnson & Johnson,…

§ July 7th, 2020 § Filed under Nano Medicine Comments Off on Latest Research on Nanomedicine Market 2020 by Application, Industry Share, End User with top players GE Healthcare, Johnson & Johnson,…

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the NanomedicineMarket which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Nanomedicine Market Players to battle Covid-19 Impact.

Theglobal Nanomedicine market has been remarkable momentum in the recent years. The NanomedicineMarket report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of Global Market. It offers detailed research and analysis of key aspects of the Nanomedicine market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the Nanomedicine market.

Top Leading players covered in the Nanomedicine market report: GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A and More

Get PDF Sample Report With Impact of COVID-19 on Nanomedicine [emailprotected] https://www.marketinforeports.com/Market-Reports/Request-Sample/101192

The Nanomedicine market report specifically highlights the market share, regional outlook, company profiles, product portfolio, a record of the recent developments, strategic analysis, GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A in the market, sales, distribution chain, manufacturing, production, new market entrants as well as existing market players, advertising, brand value, popular products, demand and supply, and other important factors related to the market to help the new entrants understand the market scenario better. the global Nanomedicine market will showcase a steady CAGR in the forecast year 2020 to 2025.

Market Segment by Type covers: Regenerative Medicine In-vitro & In-vivo Diagnostics Vaccines Drug Delivery

Market Segment by Application covers: Clinical Cardiology Urology Genetics Orthopedics Ophthalmology

Our Complimentary Sample Nanomedicine market Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology.

Inquire and Get Up to 30% DiscountBy Clicking Here! https://www.marketinforeports.com/Market-Reports/Request_discount/101192

Regions Covered in the Global Nanomedicine Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Nanomedicine Market Size: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year: 2020-2025

Highlights of the Report: Accurate market size and CAGR forecasts for the period 2019-2025 Identification and in-depth assessment of growth opportunities in key segments and regions Detailed company profiling of top players of the global Nanomedicine market Exhaustive research on innovation and other trends of the global Nanomedicine market Reliable industry value chain and supply chain analysis Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

For More Information:https://www.marketinforeports.com/Market-Reports/101192/Nanomedicine-market

Customization of the Report: Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]: https://www.marketinforeports.com/Market-Reports/Request-Customization/101192/Nanomedicine-market

Contact Us: Mr. Marcus Kel Call: +1 415 658 9988 (International) +91 84 839 65921 (IND) Email: [emailprotected] Website: http://www.marketinforeports.com

Read more from the original source:
Latest Research on Nanomedicine Market 2020 by Application, Industry Share, End User with top players GE Healthcare, Johnson & Johnson,...

Read the Rest...

Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – Morning Tick

§ July 7th, 2020 § Filed under Nano Medicine Comments Off on Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – Morning Tick

Nanomedicine Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

Nanomedicine Market Drivers and Restrains: Nanomedicine is an application of nanotechnology, which are used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine usages nanoscale manipulation of materials to improve medicine delivery. Therefore, nanomedicine has facilitated the treatment against various diseases. The nanomedicine market includes products that are nanoformulations of the existing drugs and new drugs or are nanobiomaterials. The research and development of new devices as well as the diagnostics will become, more effective, enabling faster response and the ability to treat new diseases are likely to boost the market growth.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/39223

The nanomedicine markets are driven by factors such as developing new technologies for drug delivery, increase acceptance of nanomedicine across varied applications, rise in government support and funding, the growing need for therapies that have fewer side effects and cost-effective. However, long approval process and risks associated with nanomedicine (environmental impacts) are hampering the market growth at the global level. An increase in the out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are likely to create lucrative opportunities in the nanomedicine market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nanomedicine Market Segmentation Analysis: Based on the application, the nanomedicine market has been segmented into cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. The oncology segment held the dominant market share in 2018 and is projected to maintain its leading position throughout the forecast period owing to the rising availability of patient information and technological advancements. However, the cardiovascular and neurology segment is projected to grow at the highest CAGR of XX% during the forecast period due to presence of opportunities such as demand for specific therapeutic nanovectors, nanostructured stents, and implants for tissue regeneration.

Nanomedicine Market Regional Analysis: Geographically, the Nanomedicine market has been segmented into North America, the Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the Nanomedicine market in 2018 due to the rising presence of patented nanomedicine products, the availability of advanced healthcare infrastructure and the rapid acceptance of nanomedicine. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period thanks to rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, the rising investments in research and development activities for the introduction of advanced therapies and drugs are predicted to accelerate the growth of this region in the near future.

Nanomedicine Market Competitive landscape Major Key players operating in this market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc, and Johnson & Johnson. Manufacturers in the nanomedicine are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

The objective of the report is to present a comprehensive analysis of Nanomedicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Nanomedicine Market dynamics, structure by analyzing the market segments and project the Nanomedicine Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Nanomedicine Market make the report investors guide.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/39223

Scope of the Nanomedicine Market:

Nanomedicine Market by Modality:

Diagnostics Treatments Nanomedicine Market by Diseases:

Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases Ophthalmological Diseases Immunological Diseases Nanomedicine Market by Application:

Neurology Cardiovascular Anti-Inflammatory Anti-Infectives Oncology Nanomedicine Market by Region:

Asia Pacific North America Europe Latin America Middle East Africa Nanomedicine Market Major Players:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc Johnson & Johnson Mallinckrodt plc. Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Cytimmune Sciences, Inc.

MAJOR TOC OF THE REPORT

Chapter One: Nanomedicine Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanomedicine Market Competition, by Players

Chapter Four: Global Nanomedicine Market Size by Regions

Chapter Five: North America Nanomedicine Revenue by Countries

Chapter Six: Europe Nanomedicine Revenue by Countries

Chapter Seven: Asia-Pacific Nanomedicine Revenue by Countries

Chapter Eight: South America Nanomedicine Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanomedicine by Countries

Chapter Ten: Global Nanomedicine Market Segment by Type

Chapter Eleven: Global Nanomedicine Market Segment by Application

Chapter Twelve: Global Nanomedicine Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanomedicine Market Report at:https://www.maximizemarketresearch.com/market-report/nanomedicine-market/39223/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

More:
Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region - Morning Tick

Read the Rest...

« Older Entries



Page 11234..1020..»